Key result
PCI is linked to a ~27% higher smoking continuation rate vs CABG after ACS.
Why the study?
Smoking cessation is a critical secondary prevention strategy after ACS and revascularization, but smoking behavior patterns and their associations with cardiovascular outcomes after PCI versus CABG needed examination.
Does PCI compared to CABG influence smoking continuation rates and cardiovascular outcomes in active smokers after acute coronary syndrome?
Cohort (n=128)
No
Does PCI compared to CABG influence smoking continuation rates and cardiovascular outcomes in active smokers after acute coronary syndrome?
Absolute Event Rate: 89.2% vs 70.4%
p-value: p=0.007
Patients undergoing PCI for ACS have higher rates of smoking continuation and earlier relapse compared to those undergoing CABG, highlighting the need for targeted smoking cessation support in this group.
May warrant targeted cessation support after PCI for ACS; leaves open causal effects of revascularization strategy.
Smoking cessation after acute coronary syndrome (ACS) and revascularization is a critical secondary prevention strategy. This study examined smoking behavior patterns and their associations with cardiovascular outcomes in patients who underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) following ACS. This retrospective cohort study included 128 patients who were active smokers at the time of the index ACS event and subsequently underwent PCI (n = 74) or CABG (n = 54) between 2018 and 2022. Patients were followed for a mean of 36.4 ± 12.8 months. Smoking behavior, demographic characteristics, and cardiovascular events were assessed through medical records and structured interviews. The smoking continuation rate was 81.3% (104/128) and was significantly higher in the PCI group than in the CABG group (89.2% vs. 70.4%, p = 0.007). Among patients who continued smoking, time to relapse was shorter in the PCI group (2.8 ± 1.6 vs. 5.7 ± 2.4 months, p < 0.001), and post-relapse cigarette consumption was higher (15.3 ± 6.7 vs. 12.1 ± 5.9 cigarettes/day, p = 0.018). The composite cardiovascular outcome (33.3% vs. 13.2%, p = 0.024) and repeat revascularization (43.9% vs. 7.9%, p < 0.001) were more frequent in the PCI group. Recurrent ACS was numerically more frequent in the PCI group, but the difference was not statistically significant (28.8% vs. 13.2%, p = 0.068). Smoking continuation was frequent after ACS-related coronary revascularization, particularly among PCI patients, who also experienced earlier relapse. Less favorable cardiovascular outcomes were observed among PCI patients who continued smoking; however, these findings should be interpreted as exploratory associations because of the retrospective, non-randomized design and potential residual confounding. The results highlight the need for structured, sustained, and individualized smoking cessation and relapse-prevention support after coronary revascularization.
No takes yet. Share an insight, caveat, or question.
Dursun et al. (2026) conducted a cohort in Acute coronary syndrome (ACS) requiring revascularization (n=128). Percutaneous coronary intervention (PCI) vs. Coronary artery bypass grafting (CABG) was evaluated on Smoking continuation rate (p=0.007). Percutaneous coronary intervention was associated with a significantly higher rate of smoking continuation (89.2%) compared to coronary artery bypass grafting (70.4%) following acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: